Global Genotyping 麻豆原创 Research Report 2024

Publication ID:

PB502247482

Publication Date:

February 8, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Genotyping is used to study genetic variation in the genotypes of living organisms, including humans, animals, plants, and microorganisms.
The global Genotyping market was valued at US$ 12840 million in 2023 and is anticipated to reach US$ 28170 million by 2030, witnessing a CAGR of 11.4% during the forecast period 2024-2030.
Developed regions like North America and Europe will grow comparatively slower than emerging markets like Asia-Pacific and RoW (Latin America).
This report aims to provide a comprehensive presentation of the global market for Genotyping, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genotyping.
Report Scope
The Genotyping market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genotyping market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genotyping manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Illumina
Affymetrix
Life Technologies
Agilent Technologies
Qiagen
Sequenom
Fluidigm
Beckman Coulter
Roche
GE Healthcare
Segment by Type
Polymerase Chain Reaction
Sequencing
Microarray
Electrophoresis
MALDI-TOF
Segment by Application
Pharmacogenomics
Diagnostic Research
Animal Genetics
Agricultural Biotechnology
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Genotyping manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Genotyping in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Genotyping 麻豆原创 Overview
1.1 Product Overview and Scope of Genotyping
1.2 Genotyping Segment by Type
1.2.1 Global Genotyping 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Polymerase Chain Reaction
1.2.3 Sequencing
1.2.4 Microarray
1.2.5 Electrophoresis
1.2.6 MALDI-TOF
1.3 Genotyping Segment by Application
1.3.1 Global Genotyping 麻豆原创 Value by Application: (2024-2030)
1.3.2 Pharmacogenomics
1.3.3 Diagnostic Research
1.3.4 Animal Genetics
1.3.5 Agricultural Biotechnology
1.4 Global Genotyping 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Genotyping Revenue 2019-2030
1.4.2 Global Genotyping Sales 2019-2030
1.4.3 Global Genotyping 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Genotyping 麻豆原创 Competition by Manufacturers
2.1 Global Genotyping Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Genotyping Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Genotyping Average Price by Manufacturers (2019-2024)
2.4 Global Genotyping Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Genotyping, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Genotyping, Product Type & Application
2.7 Genotyping 麻豆原创 Competitive Situation and Trends
2.7.1 Genotyping 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Genotyping Players 麻豆原创 Share by Revenue
2.7.3 Global Genotyping 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Genotyping Retrospective 麻豆原创 Scenario by Region
3.1 Global Genotyping 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Genotyping Global Genotyping Sales by Region: 2019-2030
3.2.1 Global Genotyping Sales by Region: 2019-2024
3.2.2 Global Genotyping Sales by Region: 2025-2030
3.3 Global Genotyping Global Genotyping Revenue by Region: 2019-2030
3.3.1 Global Genotyping Revenue by Region: 2019-2024
3.3.2 Global Genotyping Revenue by Region: 2025-2030
3.4 North America Genotyping 麻豆原创 Facts & Figures by Country
3.4.1 North America Genotyping 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Genotyping Sales by Country (2019-2030)
3.4.3 North America Genotyping Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Genotyping 麻豆原创 Facts & Figures by Country
3.5.1 Europe Genotyping 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Genotyping Sales by Country (2019-2030)
3.5.3 Europe Genotyping Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Genotyping 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Genotyping 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Genotyping Sales by Country (2019-2030)
3.6.3 Asia Pacific Genotyping Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Genotyping 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Genotyping 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Genotyping Sales by Country (2019-2030)
3.7.3 Latin America Genotyping Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Genotyping 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Genotyping 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Genotyping Sales by Country (2019-2030)
3.8.3 Middle East and Africa Genotyping Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Genotyping Sales by Type (2019-2030)
4.1.1 Global Genotyping Sales by Type (2019-2024)
4.1.2 Global Genotyping Sales by Type (2025-2030)
4.1.3 Global Genotyping Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Genotyping Revenue by Type (2019-2030)
4.2.1 Global Genotyping Revenue by Type (2019-2024)
4.2.2 Global Genotyping Revenue by Type (2025-2030)
4.2.3 Global Genotyping Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Genotyping Price by Type (2019-2030)
5 Segment by Application
5.1 Global Genotyping Sales by Application (2019-2030)
5.1.1 Global Genotyping Sales by Application (2019-2024)
5.1.2 Global Genotyping Sales by Application (2025-2030)
5.1.3 Global Genotyping Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Genotyping Revenue by Application (2019-2030)
5.2.1 Global Genotyping Revenue by Application (2019-2024)
5.2.2 Global Genotyping Revenue by Application (2025-2030)
5.2.3 Global Genotyping Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Genotyping Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Illumina
6.1.1 Illumina Corporation Information
6.1.2 Illumina Description and Business Overview
6.1.3 Illumina Genotyping Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Illumina Genotyping Product Portfolio
6.1.5 Illumina Recent Developments/Updates
6.2 Affymetrix
6.2.1 Affymetrix Corporation Information
6.2.2 Affymetrix Description and Business Overview
6.2.3 Affymetrix Genotyping Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Affymetrix Genotyping Product Portfolio
6.2.5 Affymetrix Recent Developments/Updates
6.3 Life Technologies
6.3.1 Life Technologies Corporation Information
6.3.2 Life Technologies Description and Business Overview
6.3.3 Life Technologies Genotyping Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Life Technologies Genotyping Product Portfolio
6.3.5 Life Technologies Recent Developments/Updates
6.4 Agilent Technologies
6.4.1 Agilent Technologies Corporation Information
6.4.2 Agilent Technologies Description and Business Overview
6.4.3 Agilent Technologies Genotyping Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Agilent Technologies Genotyping Product Portfolio
6.4.5 Agilent Technologies Recent Developments/Updates
6.5 Qiagen
6.5.1 Qiagen Corporation Information
6.5.2 Qiagen Description and Business Overview
6.5.3 Qiagen Genotyping Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Qiagen Genotyping Product Portfolio
6.5.5 Qiagen Recent Developments/Updates
6.6 Sequenom
6.6.1 Sequenom Corporation Information
6.6.2 Sequenom Description and Business Overview
6.6.3 Sequenom Genotyping Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sequenom Genotyping Product Portfolio
6.6.5 Sequenom Recent Developments/Updates
6.7 Fluidigm
6.6.1 Fluidigm Corporation Information
6.6.2 Fluidigm Description and Business Overview
6.6.3 Fluidigm Genotyping Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fluidigm Genotyping Product Portfolio
6.7.5 Fluidigm Recent Developments/Updates
6.8 Beckman Coulter
6.8.1 Beckman Coulter Corporation Information
6.8.2 Beckman Coulter Description and Business Overview
6.8.3 Beckman Coulter Genotyping Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Beckman Coulter Genotyping Product Portfolio
6.8.5 Beckman Coulter Recent Developments/Updates
6.9 Roche
6.9.1 Roche Corporation Information
6.9.2 Roche Description and Business Overview
6.9.3 Roche Genotyping Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Roche Genotyping Product Portfolio
6.9.5 Roche Recent Developments/Updates
6.10 GE Healthcare
6.10.1 GE Healthcare Corporation Information
6.10.2 GE Healthcare Description and Business Overview
6.10.3 GE Healthcare Genotyping Sales, Revenue and Gross Margin (2019-2024)
6.10.4 GE Healthcare Genotyping Product Portfolio
6.10.5 GE Healthcare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Genotyping Industry Chain Analysis
7.2 Genotyping Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Genotyping Production Mode & Process
7.4 Genotyping Sales and 麻豆原创ing
7.4.1 Genotyping Sales Channels
7.4.2 Genotyping Distributors
7.5 Genotyping Customers
8 Genotyping 麻豆原创 Dynamics
8.1 Genotyping Industry Trends
8.2 Genotyping 麻豆原创 Drivers
8.3 Genotyping 麻豆原创 Challenges
8.4 Genotyping 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Illumina
Affymetrix
Life Technologies
Agilent Technologies
Qiagen
Sequenom
Fluidigm
Beckman Coulter
Roche
GE Healthcare

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.